Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 69.53

-1.0%

Nov 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (364)	8/28/2003 12:29:29 PM
From: Jibacoa	Read Replies (1) of 3722

SQNM Has closed its August 25 Up-gap and is now trying to close above its initial resistance at the 3 level. It needs to close above 3 before it can test the August 25 close at 3.06 or its intra-day H at 3.30 Further resistance is from the 3.65 level up to the July 10 intra-day H at 3.99 SQNM revenues for the last Q were $7.7M, the same as in the 2002 2ndQ but the expenses for the Q decreased by more than 5M compared to 2002. Their Genetic Systems unit's revenues were 74% better than in the 2002 2nd Q and the loss for this unit improved to $3.6M compared to $7.9M (Moe than 50%less.) They have some collaboration going on with BMY and also have started some collaboration with ELY and PFE,from which they expect to receive milestone payments and royalties on resulting products. On June 30,SQNM reportedly held cash and equivalents of $82.9M or $2.07 cash/share. siliconinvestor.com From a longer term perspective, the chart looks very interesting with a favorable R/R and increasing OBV. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next